Abstract
Lactic acidosis has been attributed to linezolid, but its incidence has not been reported. A case of lactic acidosis in a patient was identified, and the incidence of linezolid-associated acidosis in a large university medical center was determined. The case was reviewed and the hospital database queried to identify all cases of patients receiving linezolid who developed an elevated anion gap or lactate level. There were 444 patients who received 522 unique courses of linezolid. There was no significant change in anion gap or bicarbonate with linezolid usage in the cohort. There were 14 patients who had an elevated lactate level (>3 mEq/L) and anion gap over the course of therapy. Further review yielded 1 patient who had lactic acidosis because of linezolid. Lactic acidosis was frequent in patients receiving linezolid, but linezolid appears to be a rare sole cause of lactic acidosis. Whether lactic acidosis is potentiated in individuals on linezolid could not be determined.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.